Clinical Trial Update: Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

View source ↗

Summary

This clinical trial is testing an intensive conditioning regimen consisting of Thiotepa, Busulfan, Fludarabine, and Cytarabine followed by allogeneic hematopoie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Extramedullary Myeloid Tumor
• Myelodysplastic Syndromes
• Myeloid Sarcoma
• Myelomonocytic Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Acute Myeloid Leukemia, Myelodysplastic Neoplasm | Status: RECRUITING